What is CVE-2023-33366?

CVE-2023-33366 is a high-severity vulnerability in Supremainc Biostar 2, classified under SQL Injection. CVSS score: 8.8/10. Published 2023-08-03.

How severe is CVE-2023-33366?

High severity. CVSS v3 base score is 8.8 out of 10.

SQL Injection in Supremainc Biostar 2

CVE-2023-33366

A SQL injection vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows authenticated users to inject arbitrary SQL directives into an SQL statement and execute arbitrary SQL commands.

Vulnerability class: SQL Injection

Published 2023-08-03 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.006 (48.7th percentile), scored 2026-10-29.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 49th percentile — 48.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000

Affected products

Supremainc Biostar 2

Weakness classification (CWE)

CWE-89 — SQL Injection

References

kb.supremainc.com/knowledge/doku.php (Release Notes)
claroty.com/team82/disclosure-dashboard/cve-2023-33366 (Third Party Advisory)

Frequently asked questions

What is CVE-2023-33366?: CVE-2023-33366 is a high-severity vulnerability in Supremainc Biostar 2, classified under SQL Injection. CVSS score: 8.8/10. Published 2023-08-03.
How severe is CVE-2023-33366?: High severity. CVSS v3 base score is 8.8 out of 10.